Corbus Pharmaceuticals Holdings Inc Sustainability Reports

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat serious illnesses, with a pipeline targeting oncology and obesity.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900MX6XCNZC7MM155

FIGI: BBG0078PJKP8

5 reports from 2014 to 2024

• Corbus Pharmaceuticals Holdings Inc 2024 Annual Report on Form 10-K
• Corbus Pharmaceuticals Holdings Inc 2023 Annual Report on Form 10-K
• Corbus Pharmaceuticals Holdings Inc 2022 Annual Report on Form 10-K
• Corbus Pharmaceuticals Holdings Inc 2017 Annual Report
• Corbus Pharmaceuticals Holdings Inc 2014 Annual Report on Form 10-K